Lidbree

Lidocaine, the active ingredient in Lidbree, is a local anesthetic presented as a sterile solution for intrauterine use. It provides rapid, reversible loss of sensation to facilitate intrauterine procedures such as hysteroscopy and endometrial sampling in adult patients. The anesthetic effect typically begins within minutes and lasts for a duration sufficient to complete the procedure, after which normal sensation returns.

GNH USA supplies Lidbree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and research centres worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importation.

Lidocaine is a local anesthetic used to achieve numbness in intrauterine procedures.

- Intrauterine procedures (e.g., hysteroscopy, endometrial biopsy): provides local anesthesia to reduce pain and discomfort during the intervention. - Uterine curettage: enables painless removal of uterine tissue by numbing the endometrial lining. - Diagnostic hysteroscopy: facilitates patient tolerance by eliminating sensation in the uterine cavity.

Lidocaine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Local irritation or burning at the injection site - Mild dizziness or light‑headedness - Transient numbness extending beyond the target area - Nausea or mild gastrointestinal upset - Headache - Temporary visual disturbances

Serious or Rare Side Effects: - Systemic toxicity leading to seizures - Cardiac arrhythmias or conduction disturbances - Severe allergic reactions (anaphylaxis, angioedema) - Respiratory depression - Methemoglobinemia - Persistent numbness or motor weakness

When using Lidbree, several safety considerations should be observed.

- Assess patient allergy: verify no known hypersensitivity to lidocaine or related amide anesthetics. - Monitor cardiac function: observe for arrhythmias in patients with pre‑existing heart disease. - Avoid intravascular injection: aspirate before administration to prevent systemic exposure. - Use lowest effective dose: limit total lidocaine amount per procedure as per clinical guidelines. - Store at room temperature: keep in original container, protect from moisture and light.

Lidocaine can interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma lidocaine concentrations and risk toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can elevate systemic exposure.

Moderate Interactions (Monitor Closely): - Class III antiarrhythmics (e.g., amiodarone): may potentiate cardiac effects. - Beta‑blockers: additive depressive effects on heart rate and contractility. - Concurrent use of other local anesthetics: cumulative toxicity risk requires dose adjustment.